Current DAFNE research & projects

The DAFNE Collaborative is strongly committed to research and development to improve the DAFNE program. The DAFNE Research Group is currently working on a number of studies and research programs. Some of these are listed below. You can read more about further studies by visiting the UK DAFNE website.

Australian research & projects

TEAM T1 – Teens Empowered to Actively Manage Type 1 Diabetes

TEAM T1 is a five-day group education program designed for teenagers aged 14 to 18 years with type 1 diabetes. It has been adapted for adolescents from the DAFNE program for adults with type 1 diabetes.

A pilot version of the TEAM T1 program was run at three Australian locations in 2009 and 2010, with 19 teenagers. Results showed that the program was acceptable and helpful for teenagers and their parents. Most participants had improved HbA1c levels 3 months after the program. They also reported improved confidence to manage their diabetes and less diabetes-related distress.

Another 5 years of funding for TEAM T1 was received from the Australian Government under the Chronic Disease Prevention and Service Improvement Fund. However unfortunately this program funding has now expired and there are currently no centres in Australia running TEAM T1 programs. For more information about TEAM T1, please contact This email address is being protected from spambots. You need JavaScript enabled to view it.

A pump version of DAFNE in Australia

A pump version of the DAFNE program has been running in the UK for a number of years, but funding restrictions have meant that this version has not been available in Australia. Diabetes Victoria and the NDSS have recently provided funding to get this project started. It is anticipated that the pump version of DAFNE will be available to Australian participants around the beginning of 2020. 

 

UK research & projects

Trial of 5-day vs 5-week DAFNE format

Research has shown that delivering DAFNE over a consecutive 5-day period is very effective. However, some people are unable to attend a full week program, and so miss out on doing a DAFNE course altogether. DAFNE in the UK responded to these requests by trialling an “intermittent” delivery format. These courses were delivered one day per week over five weeks (5-week DAFNE).

This research showed that there were no significant differences in outcomes for people who attended the standard 5-day courses compared with the 5-week courses. Both groups had similar improvements across all biomedical and psychosocial areas included in the study. The team concluded that both course formats should be made available. 

As a result of these research findings, a number of Australian DAFNE centres have introduced the 5-week DAFNE format. Check directly with your preferred centre to see if they are offering this format.  

REPOSE: Relative Effectiveness of Pumps Over MDI and Structured Education

Insulin pumps are sometimes seen as the ‘gold star’ method of delivering insulin to people with type 1 diabetes. This research looked at the effectiveness of pumps in comparison to multiple daily injections of insulin. One study group received the standard DAFNE program for people using MDI therapy. The second study group received DAFNE education that was adapted for people using pump therapy. 

This study showed that both groups had improvements in their diabetes management, and that pump treatment was not significantly better than multiple daily injections when DAFNE training was used. Read the full article explaining the results here

 

Irish research & projects

Ongoing care post-DAFNE

Research has shown that ongoing support assists with improving outcomes from education programs. The Irish DAFNE Study Group looked at two different methods of follow-up care after a DAFNE course. Their research also looked at economic concerns and the qualitative experiences of participants in both study groups. For more information about the results and outcomes of this research, please see the list of published articles and abstracts, or contact This email address is being protected from spambots. You need JavaScript enabled to view it.